Video

FUJIFILM Biotechnologies Capacity Update July 2025: Large Molecule Drug Substance

FUJIFILM Biotechnologies serves as a pivotal CDMO, committed to the advancement of therapeutic medicines from initial process development through to commercial production for global patient populations. This presentation details FUJIFILM Biotechnologies' strategic application of extensive expertise in microbial systems to meet the increasing demand for novel biologics. Their cutting-edge capabilities ensure streamlined development and manufacturing processes, fostering progress in therapeutic solutions and expanding the scope of biopharmaceutical innovation.

access the Video!

Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Outsourced Pharma? Subscribe today.

Subscribe to Outsourced Pharma X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Outsourced Pharma

Please tell us more about you so that we can customize our newsletters to your specific interests:

What topics interest you? (Check all that apply.)

FUJIFILM Biotechnologies